Daily1d
Merck eyes SpringWorks Therapeutics in potential pharma deal
Merck KGaA, the German healthcare and technology conglomerate, has announced that it is in advanced negotiations to acquire ...
pharmaphorum10y
Merck to acquire Sigma-Aldrich for $17 billion
The acquisition will see Sigma-Aldrich merged with the Merck Milipore business, which the company says will create an undisputed leader in the $130 billion global life sciences services industry.
Business Wire21d
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...
The Scientist10y
Merck Buys Sigma-Aldrich for $17B
having bought EMD Millipore (a.k.a. Merck Millipore), which sells reagents and lab tools, in 2010. “Sigma helps fill in a lot of the missing pieces” for Merck, Ross Muken, a life sciences ...
ABC News9d
Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China
For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion ...
Business Wire1mon
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
--(BUSINESS WIRE)--The Life Science business of Merck KGaA, Darmstadt, Germany, has acquired HUB Organoids B.V. (HUB), as announced by MilliporeSigma, the U.S. and Canada business of Merck ...
Forbes26d
What’s In Store For Merck Stock In 2025?
Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...